These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 10188656)

  • 1. Effect of immediate-release glipizide on hypoglycemic vulnerability in fasted, elderly patients with type 2 diabetes.
    Burge MR; Schmitz-Fiorentino K; Sood V; Schade DS
    JAMA; 1999 Mar 24-31; 281(12):1084-5. PubMed ID: 10188656
    [No Abstract]   [Full Text] [Related]  

  • 2. Sustained-release versus immediate-release glipizide for treatment of type 2 diabetes mellitus in chinese patients: A randomized, double-blind, double-dummy, parallel-group, 12-week clinical study.
    Hsieh SH; Lin JD; Cheng HY; Ho C; Liou MJ
    Clin Ther; 2006 Sep; 28(9):1318-26. PubMed ID: 17062305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glipizide-GITS does not increase the hypoglycemic effect of mild exercise during fasting in NIDDM.
    Riddle MC; McDaniel PA; Tive LA
    Diabetes Care; 1997 Jun; 20(6):992-4. PubMed ID: 9167112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective trial of risk factors for sulfonylurea-induced hypoglycemia in type 2 diabetes mellitus.
    Burge MR; Schmitz-Fiorentino K; Fischette C; Qualls CR; Schade DS
    JAMA; 1998 Jan; 279(2):137-43. PubMed ID: 9440664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of obesity on the pharmacokinetics and pharmacodynamics of glipizide in patients with non-insulin-dependent diabetes mellitus.
    Jaber LA; Ducharme MP; Halapy H
    Ther Drug Monit; 1996 Feb; 18(1):6-13. PubMed ID: 8848822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of hyperglycemia on glipizide absorption in NIDDM patients.
    Esmatjes E; Vinuesa P; Navarro P; Rodriguez-Villar C; Gomis R; Vilardell E
    Diabetes Care; 1995 Jul; 18(7):1075-6. PubMed ID: 7555547
    [No Abstract]   [Full Text] [Related]  

  • 7. Targeting postprandial hyperglycemia: a comparative study of insulinotropic agents in type 2 diabetes.
    Carroll MF; Gutierrez A; Castro M; Tsewang D; Schade DS
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5248-54. PubMed ID: 14602757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects and patient compliance of sustained-release versus immediate-release glipizides in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.
    Wang L; Sun X; Du L; Yuan Q; Li H; Tian H; Li Y
    J Evid Based Med; 2011 Nov; 4(4):232-41. PubMed ID: 23672754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NIDDM in the cat: treatment with the oral hypoglycemic medication, glipizide.
    Ford SL
    Vet Clin North Am Small Anim Pract; 1995 May; 25(3):599-615. PubMed ID: 7660535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of multiple dosing and age on the pharmacokinetics and pharmacodynamics of glipizide in patients with type II diabetes mellitus.
    Jaber LA; Ducharme MP; Edwards DJ; Slaughter RL; Grunberger G
    Pharmacotherapy; 1996; 16(5):760-8. PubMed ID: 8888072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of extended-release glipizide GITS compared with immediate-release glipizide in patients with type II diabetes mellitus.
    Chung M; Kourides I; Canovatchel W; Sutfin T; Messig M; Chaiken RL
    J Clin Pharmacol; 2002 Jun; 42(6):651-7. PubMed ID: 12043953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glipizide: preprandial multi-dose combination therapy capable of maintaining normal blood glucose throughout the day.
    Bernstein RK
    Diabetes Care; 1985; 8(3):306-7. PubMed ID: 4006665
    [No Abstract]   [Full Text] [Related]  

  • 13. Probable hypoglycemic adverse drug reaction associated with prickly pear cactus, glipizide, and metformin in a patient with type 2 diabetes mellitus.
    Sobieraj DM; Freyer CW
    Ann Pharmacother; 2010; 44(7-8):1334-7. PubMed ID: 20516361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled, double-blind trial.
    Testa MA; Simonson DC
    JAMA; 1998 Nov; 280(17):1490-6. PubMed ID: 9809729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The study to understand the genetics of the acute response to metformin and glipizide in humans (SUGAR-MGH): design of a pharmacogenetic resource for type 2 diabetes.
    Walford GA; Colomo N; Todd JN; Billings LK; Fernandez M; Chamarthi B; Warner AS; Davis J; Littleton KR; Hernandez AM; Fanelli RR; Lanier A; Barbato C; Ackerman RJ; Khan SQ; Bui R; Garber L; Stolerman ES; Moore AF; Huang C; Kaur V; Harden M; Taylor A; Chen L; Manning AK; Huang P; Wexler D; McCarthy RM; Lo J; Thomas MK; Grant RW; Goldfine A; Hudson MS; Florez JC
    PLoS One; 2015; 10(3):e0121553. PubMed ID: 25812009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of once-daily and twice-daily dosing on adherence with prescribed glipizide oral therapy for type 2 diabetes.
    Dezii CM; Kawabata H; Tran M
    South Med J; 2002 Jan; 95(1):68-71. PubMed ID: 11827247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of glipizide in the treatment of non-insulin dependent diabetes].
    Małecki M
    Przegl Lek; 1996; 53(9):663-5. PubMed ID: 8992533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glipizide. A review of the pharmacoeconomic implications of the extended-release formulation in type 2 diabetes mellitus.
    Foster RH; Plosker GL
    Pharmacoeconomics; 2000 Sep; 18(3):289-306. PubMed ID: 11147395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of jiang zhuo mixture on blood glucose level and insulin resistance in diabetes.
    Xiabo C; Hui W
    J Tradit Chin Med; 2005 Jun; 25(2):143-4. PubMed ID: 16136948
    [No Abstract]   [Full Text] [Related]  

  • 20. Results of a placebo-controlled study of the metabolic effects of the addition of metformin to sulfonylurea-treated patients. Evidence for a central role of adipose tissue.
    Abbasi F; Kamath V; Rizvi AA; Carantoni M; Chen YD; Reaven GM
    Diabetes Care; 1997 Dec; 20(12):1863-9. PubMed ID: 9405908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.